Aptacef S 250mg/125mg Injection
Marketer
Zeeford Life Sciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Aptacef S 250mg/125mg Injection
Cefixime and Sulbactam injection (Aptacef S 250mg/125mg) is a dual-action antibiotic combating various bacterial infections. Its mechanism halts microbial proliferation, thereby limiting infection spread. Administration must be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is vital. Complete the entire treatment course, even with symptom improvement, as premature cessation can compromise efficacy. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek urgent medical attention for any allergic reaction (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration promote quicker recovery. Your physician might order blood tests and other assessments to monitor the medication's effects.
Uses of Aptacef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Aptacef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Aptacef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Aptacef S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Aptacef S 250mg/125mg Injection works:
Aptacef S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to survive. Simultaneously, Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Aptacef S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Aptacef S (250mg/125mg) is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nonetheless, data from human clinical trials remains scarce.
Breast feedingCAUTION
Administering Aptacef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Aptacef S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Aptacef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Aptacef S 250mg/125mg, requires careful administration to individuals with significant hepatic impairment. Dosage modification for Aptacef S 250mg/125mg Injection may be necessary; physician consultation is advised. Altering the dose of Aptacef S 250mg/125mg Injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Aptacef S 250mg/125mg Injection :
Should you forget a scheduled Aptacef S 250mg/125mg Injection, seek your physician's advice.
Facts to Know About Aptacef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently